Searched for
CARDIAC THERAPY
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Trump declares himself in perfect health after physical examPresident Donald Trump underwent a physical examination. He reported everything checked out perfectly. This follows public attention on min...
- Trump, near 80, to have annual physical amid scrutiny of recent ailmentsPresident Donald Trump visited Walter Reed for his annual physical. This visit follows public attention on minor health issues. Recent phot...
- Donald Trump undergoes physical scrutiny before his 80th birthday celebrationsDonald Trump, whose birthday is June 14, became the oldest person to assume the presidency when he began his second term in January 2025.
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Mankind Pharma profit jumps 30% on chronic therapy demand in Q4Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chron...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- Cardiac drugs log highest sales in 2025 as NCD cases surgeHeart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...
- Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...
- Pharma market sees 6.1% growth in October despite subdued volumesAmongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The a...
- Domestic pharma market growth slips to 6% in JulySheetal Sapale, VP, commercial, Pharmarack, said four key therapy segments - cardiac, anti-infectives, gastro and respiratory - have driven...
- Yoga therapy shows promise for heart failure management, reports new studyA study conducted by researchers at Kasturba Medical College & Hospital in India has found that yoga therapy may be beneficial in controlli...
- India's most purchased drugs in the last decade are for cardiac ailments, diabetesAt around Rs 21,000 crore annually, cardiac medication forms the biggest therapy of drugs being bought by Indians today. A decade ago, it w...
- Stem cell therapy may mend damaged hearts, says researchEnd-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 per cent fewer cardiac events.
Load More
